日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Safety, correlative markers, and clinical results of adjuvant nivolumab in combination with vaccine in resected high-risk metastatic melanoma

纳武利尤单抗联合疫苗辅助治疗切除的高危转移性黑色素瘤的安全性、相关标志物和临床结果

Gibney, Geoffrey T; Kudchadkar, Ragini R; DeConti, Ronald C; Thebeau, Melissa S; Czupryn, Maria P; Tetteh, Leticia; Eysmans, Cabell; Richards, Allison; Schell, Michael J; Fisher, Kate J; Horak, Christine E; Inzunza, H David; Yu, Bin; Martinez, Alberto J; Younos, Ibrahim; Weber, Jeffrey S

Both tumor depth and diameter are predictive of sentinel lymph node status and survival in Merkel cell carcinoma

肿瘤深度和直径均可预测默克尔细胞癌的前哨淋巴结状态和生存率。

Smith, Franz O; Yue, Binglin; Marzban, Suroosh S; Walls, Brooke L; Carr, Michael; Jackson, Ryan S; Puleo, Christopher A; Padhya, Tapan; Cruse, C Wayne; Gonzalez, Ricardo J; Sarnaik, Amod A; Schell, Michael J; DeConti, Ronald C; Messina, Jane L; Sondak, Vernon K; Zager, Jonathan S

A phase II trial of imatinib mesylate in merkel cell carcinoma (neuroendocrine carcinoma of the skin): A Southwest Oncology Group study (S0331)

伊马替尼甲磺酸盐治疗默克尔细胞癌(皮肤神经内分泌癌)的 II 期试验:西南肿瘤协作组研究 (S0331)

Samlowski, Wolfram E; Moon, James; Tuthill, Ralph J; Heinrich, Michael C; Balzer-Haas, Naomi S; Merl, Stuart A; DeConti, Ronald C; Thompson, John A; Witter, Merle T; Flaherty, Lawrence E; Sondak, Vernon K

Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma.

白细胞介素-12质粒电穿孔治疗转移性黑色素瘤患者的I期试验

Daud Adil I, DeConti Ronald C, Andrews Stephanie, Urbas Patricia, Riker Adam I, Sondak Vernon K, Munster Pamela N, Sullivan Daniel M, Ugen Kenneth E, Messina Jane L, Heller Richard